Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride

IMPORTANCE: Case reports describe persistent erectile dysfunction (PED) associated with exposure to 5α-reductase inhibitors (5α-RIs). Clinical trial reports and the manufacturers’ full prescribing information (FPI) for finasteride and dutasteride state that risk of sexual adverse effects is not incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiguradze, Tina, Temps, William H., Yarnold, Paul R., Cashy, John, Brannigan, Robert E., Nardone, Beatrice, Micali, Giuseppe, West, Dennis Paul, Belknap, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2017
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346286/
https://www.ncbi.nlm.nih.gov/pubmed/28289563
http://dx.doi.org/10.7717/peerj.3020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346286/
https://www.ncbi.nlm.nih.gov/pubmed/28289563
http://dx.doi.org/10.7717/peerj.3020

Ejemplares similares